Abstract
The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.
Original language | English (US) |
---|---|
Pages (from-to) | 47-55 |
Number of pages | 9 |
Journal | Journal of opioid management |
Volume | 5 |
Issue number | 1 |
DOIs | |
State | Published - 2009 |
Keywords
- Infant
- Methadone
- Neonatal abstinence syndrome
- Opioids
- Substance abuse
ASJC Scopus subject areas
- Pharmacology (medical)
- Anesthesiology and Pain Medicine